首页> 外文OA文献 >In stage II/III lymph node positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumor is an indicator of better survival

【2h】

In stage II/III lymph node positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumor is an indicator of better survival

机译：在年龄小于55岁的II / III期淋巴结阳性乳腺癌患者中，角蛋白8在淋巴结转移中表达但在原发性肿瘤中不表达是更好生存的指标

页面导航

著录项
相似文献
相关主题

著录项

作者
Bonin S; Pracella D; Barbazza R; Sulfaro S; Stanta G;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival [J] . Bonin Serena, Pracella Danae, Barbazza Renzo, Virchows Archiv: an international journal of pathology . 2015,第5期

机译：在年龄小于55岁的II / III期淋巴结阳性乳腺癌患者中，角蛋白8在淋巴结转移中表达，但在原发性肿瘤中不表达，是存活率更高的指标。
2. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases. [J] . Karamitopoulou E, Zlobec I, Koumarianou A, Cancer: A Journal of the American Cancer Society . 2010,第19期

机译：在经过辅助治疗的III期大肠癌患者的淋巴结转移中p16的表达确定了预后不良的亚组：对匹配的原发肿瘤和淋巴结转移中生物标志物的回顾性分析。
3. Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer [J] . Teixeira Suzana Cipriano, Koolen Bas B., Vogel Wouter V., Clinical nuclear medicine . 2016,第4期

机译：额外的俯卧18F-FDG PET / CT采集可改善II / III期乳腺癌原发性肿瘤和局部淋巴结转移的可视化
4. Expression analysis and mass spectrometric structure characterization reveals unknown ezrin truncations in lymph node metastases of breast cancer patients [C] . Claudia Rower, Christian George, Toralf Reimer, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：表达分析和质谱结构表征揭示乳腺癌患者淋巴结转移中未知的Ezrin截短
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection or Axillary Lymph Node Dissection [O] . Jan J. Kootstra, Josette E. H. M. Hoekstra-Weebers, Johan S. Rietman, -1

机译：前哨淋巴结活检前哨淋巴结活检完整淋巴结清扫术或腋窝淋巴结清扫术治疗的I–II期乳腺癌患者手臂发病率的纵向比较
7. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups : a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases [O] . Karamitopoulou, Eva, Zlobec, Inti, Koumarianou, Anna, 2010

机译：p16在辅助治疗的III期结直肠癌患者的淋巴结转移中的表达确定了不良的预后亚组：对匹配的原发性肿瘤和淋巴结转移中的生物标志物的回顾性分析

In stage II/III lymph node positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumor is an indicator of better survival

著录项

相似文献

相关主题

期刊订阅